Articles by : Rich Daly, Editor in Chief

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

October 31, 2023 Rich Daly, Editor in Chief Views

The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.

The community benefits provided by 340B hospitals surged by $16.5 billion, or 24%, in the latest year analyzed by a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Adds Drug to Contract Pharmacy Restriction List

October 26, 2023 Rich Daly, Editor in Chief Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

GlaxoSmithKline (GSK) recently restricted 340B pricing on Jesduvroq, an anemia treatment, when providers dispense it through contract pharmacies. GSK contractor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Teva Adds Drug to Hospital Contract Pharmacy Restriction Policy

October 24, 2023 Rich Daly, Editor in Chief Views

Drugmaker Teva recently added its medication Austedo to its list of drugs under 340B contract pharmacy restrictions for hospitals.

Drug manufacturer Teva this week added a drug to the hospital contract pharmacy restrictions it first implemented in June. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

October 19, 2023 Rich Daly, Editor in Chief Views

HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.

A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Five More Providers Owe Drugmakers 340B Repayment: Audits

October 19, 2023 Rich Daly, Editor in Chief Views

HRSA confirmed it will end a pandemic-era waiver program that allowed 340B drug use in certain offsite hospital locations.

A total of 16 covered entities (CEs) owe repayment to drugmakers, five more than reported a month ago, according to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Most 340B DSH Hospitals Provide Below-Average Charity Care, Says Analysis Backed by Critics

October 19, 2023 Rich Daly, Editor in Chief Views

Bob Dold, a spokesperson for AIR340B, said the 340B program "has not translated into a stronger safety-net” after a drug industry backed analysis found 340B DSH hospitals provide below-average charity care.

The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New BMS Contract Pharmacy Policy May Target Hospital Self-Distribution, Say Attorneys

October 17, 2023 Rich Daly, Editor in Chief Views

William von Oehsen, principal at the law firm Powers, said the SUSTAIN ACT is "not going to live or die based on the user fee."

Drugmaker Bristol Myers Squibb added new language to its latest 340B contract pharmacy policy notice, which appears to target hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Says 340B Lump Sum Payments Fueled Increase in Part B Premiums, Deductibles

October 17, 2023 Rich Daly, Editor in Chief Views

CMS said planned Medicare Part B premium increases are partly the result of the proposed lump sum payment for previous illegal 340B hospital cuts.

Federal regulators recently said planned out-of-pocket increases for Medicare beneficiaries are due, in part, to the proposed lump sum payment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Audit Finds Fourth Drugmaker Owes Refunds

October 13, 2023 Rich Daly, Editor in Chief Views

Drugmaker RedHill Biopharma owes repayments to 340B covered entities, a finalized HRSA audit found.

A fourth drugmaker owes repayment to 340B covered entities, according to final audits posted this week by federal officials. RedHill [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Advocates Meet with Regulators on Lump Sum Rule

October 11, 2023 Rich Daly, Editor in Chief Views

Boris Bershteyn, an attorney representing AHA, will advocate for for changes in the 340B lump sum re-payment rule before federal regulators.

Two hospital advocacy groups are meeting with federal healthcare regulators to press their case for changes in the 340B lump [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live